FDA Grants Breakthrough Therapy Designation to NVL-520 for Metastatic ROS1+ NSCLC
The FDA has granted breakthrough therapy designation to NVL-520 for pretreated, metastatic ROS1-positive non–small cell lung cancer.
Source: onclive.com
Ros1 Positive News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ros1 Positive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ros1 Positive Today - Breaking & Trending Today
Dr Bestvina on the Management of AEs Associated With Repotrectinib in ROS1+ NSCLC
Christine Bestvina, MD, discusses strategies for managing adverse effects associated with the ROS1 TKI repotrectinib in patients with ROS1-positive metastatic non–small cell lung cancer.
Source: onclive.com